Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
2.850
-0.110 (-3.72%)
Apr 23, 2025, 11:59 AM EDT - Market open
Adverum Biotechnologies Market Cap
Adverum Biotechnologies has a market cap or net worth of $59.54 million as of April 23, 2025. Its market cap has decreased by -78.22% in one year.
Market Cap
59.54M
Enterprise Value
27.85M
1-Year Change
-78.22%
Ranking
Category
Stock Price
$2.85
Market Cap Chart
Since July 31, 2014, Adverum Biotechnologies's market cap has decreased from $581.50M to $59.54M, a decrease of -89.76%. That is a compound annual growth rate of -19.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2025 | 57.00M | -41.30% |
| Dec 31, 2024 | 97.10M | 27.60% |
| Dec 29, 2023 | 76.10M | 31.66% |
| Dec 30, 2022 | 57.80M | -66.53% |
| Dec 31, 2021 | 172.70M | -83.66% |
| Dec 31, 2020 | 1.06B | 42.01% |
| Dec 31, 2019 | 744.10M | 275.81% |
| Dec 31, 2018 | 198.00M | 25.63% |
| Dec 29, 2017 | 157.60M | 30.25% |
| Dec 30, 2016 | 121.00M | -50.65% |
| Dec 31, 2015 | 245.20M | -79.79% |
| Dec 31, 2014 | 1.21B | 108.67% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.68B |
| UnitedHealth Group | 397.68B |
| Johnson & Johnson | 378.02B |
| AbbVie | 313.53B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 225.27B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |